Enliven Therapeutics, Inc. (ELVN)
(Delayed Data from NSDQ)
$21.88 USD
-0.34 (-1.53%)
Updated Aug 30, 2024 03:59 PM ET
After-Market: $21.88 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
C Value D Growth C Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/14/2024
Time: -- |
9/2024 | $-0.55 | 0.00% |
Earnings Summary
For their last quarter, Enliven Therapeutics, Inc. (ELVN) reported earnings of -$0.41 per share, beating the Zacks Consensus Estimate of $-0.58 per share. This reflects a positive earnings surprise of 29.31%. Look out for ELVN's next earnings release expected on November 14, 2024. For the next earning release, we expect the company to report earnings of -$0.55 per share, reflecting a year-over-year decrease of 7.84%.
Earnings History
Price & Consensus
Zacks News for ELVN
3 Stocks in the Limelight on New Analyst Coverage
ELVN: What are Zacks experts saying now?
Zacks Private Portfolio Services